In November, the production end of sodium-ion battery cathode materials performed impressively, with production up 50% MoM and 54% YoY, indicating a continuous recovery in industry prosperity. In ...
Yes, the title is clickbaity and provocative, but as a CTO with many years in data, I’ve witnessed a transformation that justifies the drama. The traditional “data team” – the back-office crew ...
In November, the production end of sodium-ion battery cathode materials performed impressively, with production up 50% MoM and 54% YoY, indicating a continuous recovery in industry prosperity. In ...
To understand what these improvements mean in practice, we spoke with Kiran Gadhave, software engineer and IEEE Senior Member ...
Ontada®, a McKesson business dedicated to real-world oncology data and insights, will present findings from a retrospective cohort study at ASH 2025.
Women who used a GLP-1 prior to pregnancy and stopped therapy 1 to 2 years before delivery had increased risk for preeclampsia, but reduced risk for developing gestational diabetes, according to study ...
The following highlights showcase key research presented at the European Society for Medical Oncology (ESMO) 2025 Congress.
The payback for this investment is around two to three years, according to a survey from MIT Intelligent Logistics Systems.
Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy ...
Background Is being famous a risk factor for premature death? Previous studies indicate that famous musicians have a higher ...
4don MSN
Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating
Viking Therapeutics, Inc. (NASDAQ:VKTX) ranks among the best short squeeze stocks to buy right now. On November 20, H.C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback